NovoCure (NASDAQ:NVCR) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

NovoCure missed estimated earnings by 53.33%, reporting an EPS of $-0.23 versus an estimate of $-0.15.

Revenue was up $7.35 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14 which was followed by a 0.78% drop in the share price the next day.

Here's a look at NovoCure's past performance:

To track all earnings releases for NovoCure visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.